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Abstract
Background: Hypertension is a growing problem worldwide, markedly in low- and middle-income countries, where the rate
of control slightly decreased. The overall prevalence of hypertension in Brazil is 28.7% among adult individuals and 68.9% in
the population aged 60 years and older, and less than a third of patients have controlled blood pressure (BP). The use of
technologies—mobile phones and the internet—to implement interventions to reduce blood pressure can minimize costs and
diminish cardiovascular risk. Interventions through text messaging and electronic BP monitoring present divergent results.
Objective: This trial evaluates the effectiveness of interventions—personalized messages and telemonitoring of BP—to reduce
systolic BP and improve lifestyle compared to the usual care of patients with hypertension (control group).
Methods: This factorial randomized controlled trial enrolls individuals aged 30 to 75 years who have a mobile phone and internet
access with the diagnosis of hypertension under drug treatment with up to 2 medications and uncontrolled BP. Eligible participants
should have both increased office BP and 24-hour BP with ambulatory BP monitoring. Participants with severe hypertension
(systolic BP ≥180 or diastolic BP ≥110 mm Hg), life threatening conditions, low life expectancy, recent major cardiovascular
event (last 6 months), other indications for the use of antihypertensive medication, diagnosis of secondary hypertension, pregnant
or lactating women, or those unable to understand the interventions are excluded. Participants are randomly allocate to 1 of 4
experimental arms: (1) Telemonitoring of blood pressure (TELEM) group: receives an automatic oscillometric device to measure
BP, (2) telemonitoring by text message (TELEMEV) group: receives personalized, standardized text messages to stimulate lifestyle
changes and adhere with BP-lowering medication, (3) TELEM-TELEMEV group: receives both interventions, and (4) control
group: receives usual clinical treatment (UCT). Data collection is performed in a clinical research center located in a referent
hospital. The primary outcomes are reduction of systolic BP assessed by 24-hour ambulatory BP monitoring (primary outcome)
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and change of lifestyle (based on dietary approaches to stop hypertension (DASH)-type diet, sodium restriction, weight loss or
control, increase of physical activity).
Results: This study was funded by two Brazilian agencies: the National Council for Scientific and Technological Development
and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul. Enrollment was completed at the end of 2017 (N=231),
the follow-up is ongoing, and data analysis is expected to begin in early 2019. A reduction of 24-hour systolic BP of approximately
8.8 [SD 13.1] mm Hg for participants in the BP monitoring group versus 3.4 [SD 11.6] mm Hg in the UCT group is expected. A
similar reduction in the text messaging group is expected.
Conclusions: The use of mobile technologies connected to the internet through mobile phones promotes time optimization, cost
reduction, and better use of public health resources. However, it has not been established whether simple interventions such as
text messaging are superior to electronic BP monitoring and whether both outperform conventional counseling.
Trial Registration: ClinicalTrials.gov NCT03005470; https://clinicaltrials.gov/ct2/show/NCT03005470 (Archived by WebCite
at http://www.webcitation.org/70AoANESu). Plataforma Brasil CAAE 31423214.0.0000.5327.
Registered Report Identifier: RR1-10.2196/9619
(JMIR Res Protoc 2018;7(8):e169)   doi:10.2196/resprot.9619
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Introduction
Hypertension is a growing problem worldwide, markedly in
low- and middle-income countries where increased prevalence
was not followed up by higher awareness and control rates [1].
The overall prevalence of hypertension in Brazil is 28.7% (95%
CI 26.2% to 31.4%) among adults [2] and 68.9% (95% CI 64.1%
to 73.3%) in the population aged 60 years and older [3], and
less than a third of patients have controlled blood pressure (BP).
Low- and middle-income countries may even be facing a
persistent increase of individuals with high BP in the next decade
[1,4]. Successful attempts have been shown to increase BP
control [5,6] but have not been implemented in clinical practice.
In recent years, the spectrum of interventions to increase
hypertension control and reduce cardiovascular risk factors has
widened as researchers seek alternatives that do not overburden
the public health system [7]. The use of technologies using
mobile phones and the internet to implement interventions can
improve BP control, minimize health care resource use and
costs [8], and reduce cardiovascular risk [7,9]. However, the
effectiveness of these approaches depends on patient adherence
to both types of interventions—behavioral and pharmacological
[10]. Several randomized controlled trials (RCTs) have evaluated
nonpharmacological interventions to reduce BP [5,6,11] and,
in some studies, stimuli for lifestyle changes [12-14]. Text
messaging interventions implemented in individuals with
hypertension showed a small impact on BP compared to usual
care [15]. In addition, similar levels of BP control have been
observed with electronic monitoring and usual care [16].
Meaningful reductions in BP were observed with interventions
involving frequent visits to a family doctor and adjustments of
the therapeutic regimen [17], home BP monitoring [5], and
home BP monitoring combined with medication titration,
education, or lifestyle counseling [11]. Individuals with coronary
heart disease undergoing an intervention based only on text
messaging to improve lifestyle had a significant reduction of
cardiovascular risk factors [18]; no clear-cut results were
observed with an intervention based on text messages to improve
medication adherence [19].
Innovative technologies can be used to achieve BP reduction,
but it remains unknown if interventions should be focused only
on hypertension control or should address lifestyle as well.
Therefore, the purpose of this study is to compare the
effectiveness of 3 strategies to reduce systolic BP assessed by
ambulatory BP monitoring and improve lifestyle in comparison
to the usual care of patients with hypertension (usual clinical
treatment [UCT], control group). Our hypothesis is that
participants assigned to active interventions will achieve greater
BP reduction than those in the control group. The intervention
by text messaging (TELEMEV) is a stimulus for adoption of a
healthy lifestyle that may reduces BP, while telemonitoring of
BP (TELEM) can enhance adherence to antihypertensive
medication and stimulate healthy lifestyle. In addition, we
hypothesized that participants who receive the combined
intervention (TELEM+TELEMEV) will obtain greater reduction
in BP than those submitted to individual interventions.
Methods
Study Design
This is a factorial RCT (Figure 1) of effectiveness of the use of
technologies—mobile phones and BP monitoring—to reduce
systolic BP and change lifestyle. Figure 2 shows that participants
are randomly allocated to 1 of 4 groups: telemonitoring BP
(TELEM), telemonitoring messages (TELEMEV),
telemonitoring BP plus telemonitoring messages
(TELEM+TELEMEV), or UCT, with an allocation ratio of
1:1:2:1.
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Figure 1. Factorial design of the trial showing the groups. TELEM: telemonitoring of blood pressure; TELEMEV: telemonitoring by text message;
UCT: usual clinical treatment.
Figure 2. Overall design of the trial. ABPM: Ambulatory Blood Pressure Monitoring; BP: blood pressure; TELEM: telemonitoring of blood pressure;
TELEM: telemonitoring by text message.
Figure 3. Study flowchart. usual clinical treatment. TELEM: telemonitoring of blood pressure; TELEMEV: telemonitoring by text message.
Study Participants
Participants are recruited from primary care clinics face to face
or by phone call to screen for eligibility or online advertisement.
Figure 3 shows the screening of potential participants performed
in 2 clinics, a Family Health Strategy and a Basic Health Care
Unit. Eligible participants must be aged 30 to 75 years, have
hypertension, be undergoing treatment with up to 2 medications
for lowering BP, and possess a mobile phone with internet
access.
The choice of antihypertensive medications is made prior to the
trial at the discretion of the attending physician, and no titration
of medications is made during the trial. Office standardized BP
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measurement is evaluated 4 times at the screening visit and 3
times in each eligibility visit. The first BP measurements are
discarded, and an average systolic BP of ≥135 or diastolic BP
of ≥85 mm Hg is required to be eligible, as well as systolic BP
of ≥130 or diastolic BP ≥80 mm Hg in 24-hour ambulatory BP
monitoring.
Participants with severe hypertension (systolic BP of ≥180 or
diastolic BP of ≥110 mm Hg), life-threatening conditions, low
life expectancy, other indications for antihypertensive
medication, major cardiovascular event (acute myocardial
infarction, stroke) in the last 6 months, diagnosis of secondary
hypertension, participants from another RCT in the last 6
months, pregnant or lactating women, or those unable to
understand the interventions are excluded. Data collection is
performed at a clinical research center, Hospital de Clinicas de
Porto Alegre, in southern Brazil. Automated office BP is also
performed 6 times at each eligibility visit [20].
Interventions
Participants in the 4 groups receive an illustrated booklet with
recommendations for a healthy lifestyle and are required to
adhere to the BP-lowering medications. In addition, participants
who receive the active interventions are scheduled for an
individual personalized session in which the booklet information
is explained and specific recommendations are highlighted. The
4 arms are as follows:
• TELEM group: participants receive an automatic
oscillometric device to measure BP 5 days a week and at
least 1 day on the weekend. Participants are trained to use
the monitor and instructed to perform 4 measurements per
day (2 in the morning and 2 in the evening) using a
standardized technique. Measurements are captured from
the BP monitor by software developed for the study that
also sends the BP measurements to the study coordination
center. The software is adapted according to the participant's
mobile phone brand and iOS or Android version. After BP
measurements are sent to the data center, participants
receive a prompt on the mobile phone with information
about the value. At the end of the trial, participants will
return the BP monitor.
• TELEMEV group: participants receive personalized,
standardized text messages to stimulate lifestyle changes
and adhere to BP-lowering medication. Messages focus on
the adoption of dietary approaches to stop hypertension
(DASH)-type diet, sodium restriction, reduction of alcohol
intake, increase of physical activity, weight loss or control,
and daily intake of BP-lowering medications. These
messages are sent to mobile phones on 4 random business
days at random business hours using software developed
for the study. There is no contact other than the messages
on the mobile phone. At the end of the trial, participants
have no further access to the messages.
• TELEM-TELEMEV group: participants receive both
interventions, telemonitoring of BP plus telemonitoring
messages, as previously described.
• UCT: participants of the control group start the trial already
on antihypertensive treatment, chosen at the discretion of
the attending physician. At randomization, they receive a
brief counseling about healthy lifestyle choices using the
information in the booklet. Participants will not receive any
technological tools to stimulate BP control or lifestyle
modification.
Outcomes and Their Assessment
Primary outcome is 24-hour systolic BP measured using
ambulatory BP monitoring with the Ambulo ABP 2400 (Mortara
Instrument) or Spacelabs 90207 (Spacelabs Healthcare)
programmed to take measurements every 15 minutes from 0700
to 2300 hours and every 20 min from 2300 to 0700 hours. Office
BP is assessed using an automatic oscillometric device (Omron
HBP-1100 or HEM-705 CPN, Omron Healthcare Inc), and the
average of 4 out of 6 measurements is used. Table 1 shows
primary and secondary outcomes and their operational
definitions.
Randomization and Allocation Concealment
A computer-generated sequence was created in the random
allocation software [22], which is used to randomly assign
participants to 1 of 4 groups using permuted random block sizes
of 4 and 8. The randomization sequence was generated prior to
the trial initiation and is kept in the Research Electronic Data
Capture software, which releases the allocated group only after
completion of the enrollment. Just after completion of the
enrollment of a participant, the randomized group is released,
preventing the research team from anticipating to which arm
the next participant will be allocated. Follow-up visits are
scheduled for 7, 30, 90, and 180 days from randomization. At
the 7-day visit, participants in the intervention groups can
address any problems with image capture or text messages. The
protocol was registered in the Plataforma Brasil (CAAE:
31423214000005327), a condition to be submitted to the Ethics
Committee. It was approved by the Ethics Committee of the
Hospital de Clinicas de Porto Alegre (GPPG number 16-0187),
which is accredited by the Office of Human Research
Protections as an institutional review board. After the
institutional approval, the protocol was registered with
ClinicalTrials.gov [NCT03005470]. A written informed consent
is obtained from all participants according to the principles
expressed in the Declaration of Helsinki. Potentially eligible
participants will be evaluated in 3 consecutive clinical visits,
held in the morning, in order to confirm eligibility criteria.
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Table 1. Description of clinical and laboratory outcomes and their definitions.
Secondary outcomesPrimary outcomeOutcomes and definitionsa
Blood pressure
XReduction in 24-hour systolic blood pressure in ambulatory blood pressure monitoring
XReduction in 24-hour diastolic blood pressure in ambulatory blood pressure monitoring
XReduction in daytime systolic blood pressure
XReduction in nighttime systolic blood pressure
XOffice BP control (<130/80 mm Hg) [21]
Sodium restriction
XReduction in sodium urinary excretion (urinary spot)
Healthy diet
XIncrease in reported dietary intake (24-hour recall of food groups)
Alcohol intake
XReduction of reported intake (grams of ethanol per day)
Physical activity
XIncrease in average steps taken during 7 days (pedometer counting)
Weight loss
XReduction of at least 3 kg and average reduction
aReduction or increase is calculated based on baseline and end of trial assessments.
Table 2. Sample size calculations based on a previous trial [5] and additional simulations maintaining constant 80% power and 95% confidence interval.
Total sample
size
Calculated sample size per
group
Average reduction in the control group,
mm Hg (SD)
Average reduction in the intervention group,
mm Hg (SD)
Intervention-to-
control ratio
124313.4 (11.6)8.8 (13.1)1:1:1:1
156393.4 (11.6)7.8 (13.1)1:1:1:1
204513.4 (11.6)6.8 (13.1)1:1:1:1
13244/223.4 (11.6)8.8 (13.1)1:1:1:2
16856/283.4 (11.6)7.8 (13.1)1:1:1:2
22274/373.4 (11.6)6.8 (13.1)1:1:1:2
Assessments During the Trial
The presence of risk factors associated with raised BP and
cardiovascular risk are determined using standardized
questionnaires in face-to-face interviews performed by staff
members with undergraduate degrees in nutrition, biomedicine,
or biology. Evaluations are performed at the beginning and end
of the study using standardized interviews on prior morbidity,
drug use, eating habits, and lifestyle. At the clinic, measurements
are taken of weight; height; waist, hip, and neck circumferences;
estimated body composition (bioelectrical impedance analysis);
electrocardiography; retinography; and laboratory evaluation
of cholesterol and fractions, triglycerides, fasting glucose,
glycated hemoglobin A1c, creatinine, potassium, C-reactive
protein, and urinary sodium. At home, measurements are taken
of capillary glucose (before breakfast and dinner for 3 days;
Accu-Chek glucose meter, Roche Diabetes Care Inc) and step
count (Omron HJ-112 digital pocket pedometer, Omron
Healthcare Inc) during the waking hours for 7 days. Participants
have BP recorded in the office using an automatic oscillometric
device and at home using a Spacelabs 90207 monitor (Spacelabs
Healthcare).
In addition, participants are instructed not to change doses or
type of antihypertensive medication during the trial.
Sample Size Calculation and Statistical Analysis
The sample size calculation is based on results from a prior
RCT with a factorial design [5]. Table 2 shows simulations for
sample size calculations maintaining constant 80% power and
95% confidence interval. The largest sample size was obtained
for a BP reduction of 6.8 [SD 13.1] mm Hg on 24-hour systolic
BP in the intervention group compared to 3.4 [SD 11.6] mm
Hg in the usual care treatment. Therefore, a sample of at least
222 participants is necessary to test our hypothesis.
Trial results will be analyzed using the intention-to-treat
approach. The effectiveness of the active interventions will be
tested in comparison to the control group. A pooled analysis of
the differences between the active interventions versus control
will be performed if there is no interaction. For continuous
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variables, the assumptions to use t tests will be verified using
the Shapiro-Wilks test (for normal distribution) and the Levene
test (for homogeneity of variance), and equal variances are
assumed. Therefore, baseline characteristics will be analyzed
using the t test for independent samples and chi-square test for
categorical variables. Generalized estimating equations models
will used to analyze the group, time, and time × group
differences. The relative risk will be used to determine the
corresponding relative risk reduction. P<.05 will be considered
statistically significant, and .05<P<.15 will be considered a
trend toward association.
Results
This RCT was funded by two Brazilian agencies, and the results
can be used to redefine public health policies. Data collection
is ongoing and results are expected in early 2019. A 24-hour
reduction in systolic BP of approximately 8.8 mm Hg is
anticipated for participants in the electronic BP monitoring
group with a similar effect in the text messaging group, against
3.4 mm Hg reduction in the usual care group. This reduction is
clinically relevant and capable of impacting cardiovascular
mortality. The two active interventions (TELEM and
TELEMEV) are likely to provide equivalent benefits and, in
this scenario, would be favorable to usual care in the public
health system. Text messages seems to be more easily
implemented at a lower cost.
Discussion
Lowering Blood Pressure
Hypertension is an inexorable and progressive condition that
has deleterious effects on the heart, brain, and vascular system.
Reducing BP and increasing control of hypertension are the
main targets of interventions. However, if possible, the best
intervention should be that which doesn’t require additional
BP-lowering medications. Thus, any intervention capable of
lowering BP or increasing BP control and, at the same time,
attenuating other cardiovascular risk factors could represent an
advantageous step in treatment.
This trial is the first to comprehensively compare two strategies
for reducing BP and risk factors in cardiovascular disease.
Results from previous trials have indicated the potential
beneficial impact of self-monitoring programs [23], home blood
pressure monitoring [5], and text messages [24], but these
interventions have not been compared or assessed regarding
other cardiovascular risk factors. The sample size, although
larger than other trials, might be a limitation to test the secondary
hypothesis.
Conclusions
The evaluation of different health interventions allows us to
select the most effective and lowest cost treatment to implement
in clinical practice.
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